Nov 14 (Reuters) - Cardiome Pharma Corp
* Cardiome reports third quarter 2017 financial results
* Sees fy 2017 revenue $24 million to $26 million
* Q3 revenue $6.0 million versus I/B/E/S view $7.3 million
* Q3 loss per share $0.20
* Q3 earnings per share view $-0.18 -- Thomson Reuters I/B/E/S
* Cardiome Pharma Corp - expects existing cash and cash equivalents will be sufficient to fund its operations for at least next 12 months. Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.